• Injection
  • Febrile neutropenia
  • In non-myeloid malignancies
  • In patients undergoing myeloablative chemotherapy followed by marrow transplantation; Prophylaxis Febrile neutropenia
  • In non-myeloid malignancies following myelosuppressive chemotherapy; Prophylaxis Febrile neutropenia
  • In patients with acute myeloid leukemia receiving chemotherapy; Prophylaxis Harvesting of peripheral blood stem cells Neutropenic disorder
  • Chronic (Severe)
Back to: Full Site NavigationSkip to: side effects sectionSkip to: What to expect sectionSkip to: Risks and warnings sectionSkip to: Common concerns from users and pharmacists
Skip Upsides & Downsides section. Skip to side effects section.
No pricing data for this drug at this filter setting. Try searching onGoodRx
Skip side effects section. Skip to What to Expect and Pharmacists Tips section.

Side effect rates for Neupogen (Filgrastim)

0 reports
These are side effects of Neupogen (Filgrastim) reported to the FDA by people taking it, and by doctors and pharmacists.
Filter group. All currently selected
Filter group. All currently selected

Common concerns from people taking Neupogen (Filgrastim)

Final section. Do you want to return to drug navigation?